Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biden Promises 500 Million COVID-19 Tests As Omicron Threatens To Overwhelm US Health Care System

Executive Summary

The “President’s Winter Plan” to fight the new variant includes mailing out free COVID-19 take-home tests to Americans who ask for it. AdvaMed says it will encourage manufacturers to keep producing tests.

You may also be interested in...



Industry Urged White House To Invest In COVID-19 Tests Long Before Current Shortage: AdvaMed

The lobby group says the takeaway from the test shortage is the government should engage industry to prepare and ramp up test production before the next wave of variant infections in the ongoing pandemic.

JPM 2022: Abbott, iRhythm, Novocure, Zimmer Biomet

The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022 as they continue to cope with the impact of the Omicron surge. Here are some of the highlights from the presentations on the second day of the meeting.

Top Republican Senators Criticize Biden Administration For Lack Of COVID-19 Tests

The top GOPers on the Senate health committee want to know what the administration has done with more than $80bn allocated by Congress to ramp up production of COVID-19 tests.

Related Content

Topics

UsernamePublicRestriction

Register

MT144870

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel